EFFECTS OF HEPARIN AND DALTEPARIN ON OXIDATIVE STRESS DURING HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NASIRI A.A.; HAKEMI M.A.S.; SOULATI M.; MARASHIAN S.M.; RAHBAR KH.; AZIZI FEREYDOUN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Journal of Kidney Diseases Year:2009 | Volume:3 | Issue:3 Page(s): 162-167

Download Full-Text

View:

387

Download:

170

Cites:

Information Journal Paper

Title

EFFECTS OF HEPARIN AND DALTEPARIN ON OXIDATIVE STRESS DURING HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE

Author(s)

Keywords

HEPARIN

DALTEPARIN

HEMODIALYSIS

OXIDATIVE STRESS

END-STAGE RENAL DISEASE

Abstract

Introduction: Dialysis-induced OXIDATIVE STRESS is one of the mechanisms of atherosclerotic changes. HEPARIN, used in HEMODIALYSIS, is an anticoagulant drug with anti-inflammatory and antioxidant effects. This study was planned in order to evaluate the antioxidant effects of HEPARIN and DALTEPARIN (low-molecular weight HEPARIN). Materials and Methods: Twenty-two patients underwent 3 HEMODIALYSIS sessions with 48-hour intervals. They underwent HEMODIALYSIS with HEPARIN, with a bolus dose of 1000 U followed by 1000 U/h during the procedure. The second HEMODIALYSIS was done using hypertonic saline solution instead of HEPARIN, and the third, using DALTEPARIN, 4000 U, infused during HEMODIALYSIS. Before and after each dialysis session, we measured serum levels of total blood cholesterol, triglyceride, high- and low-density lipoprotein cholesterols and oxidized low-density lipoprotein cholesterol, in addition to total antioxidant capacity and paraoxonase 1 activity.Results: Serum concentrations of triglyceride, cholesterol, and oxidized low-density lipoprotein cholesterol, as well as paraoxonaseactivity and total antioxidant capacity equally increased after the three HEMODIALYSIS sessions. HEPARIN and daltepain increased total antioxidant capacity, but they did not change the ratio of paraoxonase 1 to high-density lipoprotein cholesterol after HEMODIALYSIS. No significant differences were found through the study between the two HEPARIN products in their antioxidant activities. Conclusions: Regarding these findings and considering higher price and less availability of DALTEPARIN in comparison to conventional HEPARIN, we recommend using conventional HEPARIN during HEMODIALYSIS as the anticoagulant-antioxidant agent.

Cites

No record.

References

Cite

APA: Copy

NASIRI, A.A., HAKEMI, M.A.S., SOULATI, M., MARASHIAN, S.M., RAHBAR, KH., & AZIZI, FEREYDOUN. (2009). EFFECTS OF HEPARIN AND DALTEPARIN ON OXIDATIVE STRESS DURING HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 3(3), 162-167. SID. https://sid.ir/paper/308746/en

Vancouver: Copy

NASIRI A.A., HAKEMI M.A.S., SOULATI M., MARASHIAN S.M., RAHBAR KH., AZIZI FEREYDOUN. EFFECTS OF HEPARIN AND DALTEPARIN ON OXIDATIVE STRESS DURING HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2009;3(3):162-167. Available from: https://sid.ir/paper/308746/en

IEEE: Copy

A.A. NASIRI, M.A.S. HAKEMI, M. SOULATI, S.M. MARASHIAN, KH. RAHBAR, and FEREYDOUN AZIZI, “EFFECTS OF HEPARIN AND DALTEPARIN ON OXIDATIVE STRESS DURING HEMODIALYSIS IN PATIENTS WITH END-STAGE RENAL DISEASE,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 3, no. 3, pp. 162–167, 2009, [Online]. Available: https://sid.ir/paper/308746/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops